MICROGESTIN 24 FE (NORETHINDRONE ACETATE-ETHINYL ESTRADIOL/FERROUS FUMARATE)
- Pregnancy contraception
- Tarina 24 Fe Tablet
- Larin 24 Fe Tablet
- Junel Fe 24 Tablet
- Hailey 24 Fe Tablet
- Blisovi 24 Fe Tablet
- Aurovela 24 Fe Tablet
- By Indication
1 mg-20 mcg (24)/75 mg (4) tablet
- 1 tablet by oral route once daily
1 mg-20 mcg (24)/75 mg (4) tablet
- 1 tablet by oral route once daily
1 mg-20 mcg (24)/75 mg (4) tablet
- 1 tablet by oral route once daily
1 mg-20 mcg (24)/75 mg (4) tablet
- 1 tablet by oral route once daily
1 mg-20 mcg (24)/75 mg (4) tablet
- 1 tablet by oral route once daily
1 mg-20 mcg (24)/75 mg (4) tablet
- 1 tablet by oral route once daily
Acne vulgaris
- 1 tablet by oral route once daily
Pregnancy contraception
- 1 tablet by oral route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- None
MICROGESTIN 24 FE (NORETHINDRONE ACETATE-ETHINYL ESTRADIOL/FERROUS FUMARATE)
- Pregnancy contraception
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Combination Oral Contraceptives
- Severity Level:
2
- Additional Notes: Avail data no known risk for developmental toxicity after inadvertent exposure
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Estrogenic Agents (systemic)
General-Use lowest possible dose for shortest duration and in combination with a progestin as indicated to reduce the risk of endometrial hyperplasia and breast cancer. Cardiovascular-May increase risk for thromboembolic events. Avoid use in patients with known, suspected, or history of arterial or venous thromboembolic disease. Neuro/Psych-May increase the risk for dementia. Genitourinary-May aggravate urinary incontinence.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | Y | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- Do not use this medication if you smoke cigarettes/use tobacco and are over 35 years old. Smoking raises your risk of stroke, heart attack, blood clots, and high blood pressure from hormonal birth control (such as the pill, patch, ring). The risk of these serious problems increases with age and with the number of cigarettes you smoke.<br /><br />Do not smoke or use tobacco. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children younger than 6 years. Keep this product out of reach of children. If overdose does occur, get medical help right away or call a poison control center.
Pregnancy contraception | |
Z30 | Encounter for contraceptive management |
Z30.01 | Encounter for initial prescription of contraceptives |
Z30.011 | Encounter for initial prescription of contraceptive pills |
Z30.013 | Encounter for initial prescription of injectable contraceptive |
Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
Z30.015 | Encounter for initial prescription of vaginal ring hormonal contraceptive |
Z30.016 | Encounter for initial prescription of transdermal patch hormonal contraceptive device |
Z30.017 | Encounter for initial prescription of implantable subdermal contraceptive |
Z30.018 | Encounter for initial prescription of other contraceptives |
Z30.019 | Encounter for initial prescription of contraceptives, unspecified |
Z30.4 | Encounter for surveillance of contraceptives |
Z30.40 | Encounter for surveillance of contraceptives, unspecified |
Z30.41 | Encounter for surveillance of contraceptive pills |
Z30.42 | Encounter for surveillance of injectable contraceptive |
Z30.43 | Encounter for surveillance of intrauterine contraceptive device |
Z30.430 | Encounter for insertion of intrauterine contraceptive device |
Z30.431 | Encounter for routine checking of intrauterine contraceptive device |
Z30.433 | Encounter for removal and reinsertion of intrauterine contraceptive device |
Z30.44 | Encounter for surveillance of vaginal ring hormonal contraceptive device |
Z30.45 | Encounter for surveillance of transdermal patch hormonal contraceptive device |
Z30.46 | Encounter for surveillance of implantable subdermal contraceptive |
Z30.49 | Encounter for surveillance of other contraceptives |
Z30.8 | Encounter for other contraceptive management |
Z30.9 | Encounter for contraceptive management, unspecified |
Z79.3 | Long term (current) use of hormonal contraceptives |
Z97.5 | Presence of (intrauterine) contraceptive device |
0-9 | A-Z |
---|---|
Z30 | Encounter for contraceptive management |
Z30.01 | Encounter for initial prescription of contraceptives |
Z30.011 | Encounter for initial prescription of contraceptive pills |
Z30.013 | Encounter for initial prescription of injectable contraceptive |
Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
Z30.015 | Encounter for initial prescription of vaginal ring hormonal contraceptive |
Z30.016 | Encounter for initial prescription of transdermal patch hormonal contraceptive device |
Z30.017 | Encounter for initial prescription of implantable subdermal contraceptive |
Z30.018 | Encounter for initial prescription of other contraceptives |
Z30.019 | Encounter for initial prescription of contraceptives, unspecified |
Z30.4 | Encounter for surveillance of contraceptives |
Z30.40 | Encounter for surveillance of contraceptives, unspecified |
Z30.41 | Encounter for surveillance of contraceptive pills |
Z30.42 | Encounter for surveillance of injectable contraceptive |
Z30.43 | Encounter for surveillance of intrauterine contraceptive device |
Z30.430 | Encounter for insertion of intrauterine contraceptive device |
Z30.431 | Encounter for routine checking of intrauterine contraceptive device |
Z30.433 | Encounter for removal and reinsertion of intrauterine contraceptive device |
Z30.44 | Encounter for surveillance of vaginal ring hormonal contraceptive device |
Z30.45 | Encounter for surveillance of transdermal patch hormonal contraceptive device |
Z30.46 | Encounter for surveillance of implantable subdermal contraceptive |
Z30.49 | Encounter for surveillance of other contraceptives |
Z30.8 | Encounter for other contraceptive management |
Z30.9 | Encounter for contraceptive management, unspecified |
Z79.3 | Long term (current) use of hormonal contraceptives |
Z97.5 | Presence of (intrauterine) contraceptive device |